Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Dec;32(4):373-81.
doi: 10.1007/s00281-010-0227-7. Epub 2010 Sep 21.

MHC presentation via autophagy and how viruses escape from it

Affiliations
Free article
Review

MHC presentation via autophagy and how viruses escape from it

Monique Gannage et al. Semin Immunopathol. 2010 Dec.
Free article

Abstract

T cells detect infected and transformed cells via antigen presentation by major histocompatibility complex (MHC) molecules on the cell surface. For T cell stimulation, these MHC molecules present fragments of proteins that are expressed or taken up by the cell. These fragments are generated by distinct proteolytic mechanisms for presentation on MHC class I molecules to cytotoxic CD8(+) and on MHC class II molecules to helper CD4(+) T cells. Proteasomes are primarily involved in MHC class I ligand and lysosomes, in MHC class II ligand generation. Autophagy delivers cytoplasmic material to lysosomes and, therefore, contributes to cytoplasmic antigen presentation by MHC class II molecules. In addition, it has been recently realized that this process also supports extracellular antigen processing for MHC class II presentation and cross-presentation on MHC class I molecules. Although the exact mechanisms for the regulation of these antigen processing pathways by autophagy are still unknown, recent studies, summarized in this review, suggest that they contribute to immune responses against infections and to maintain tolerance. Moreover, they are targeted by viruses for immune escape and could maybe be harnessed for immunotherapy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Blood. 2005 Apr 15;105(8):3199-205 - PubMed
    1. Nat Cell Biol. 2009 Dec;11(12):1433-7 - PubMed
    1. J Immunol. 2009 Nov 1;183(9):5909-16 - PubMed
    1. Eur J Immunol. 2008 Aug;38(8):2090-5 - PubMed
    1. Virology. 1965 Jul;26:379-89 - PubMed

Publication types

MeSH terms

Substances